Shugart Y Y, Hemminki K, Vaittinen P, Kingman A
Center for Inherited Disease Research, Department of Pediatrics, Johns Hopkins University, USA.
Leuk Lymphoma. 2001 Jul;42(3):407-15. doi: 10.3109/10428190109064598.
The goal of this study was to test whether there is genetic anticipation in Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). We analyzed 102 parent-child pairs with HD or NHL, based upon the Swedish Cancer Database. We identified 18 sib-pairs (2 HD and 16 NHL) and 102 parent-child pairs (13 HD/HD, 56 NHL/NHL, 25 HD/NHL, and 8 NHL/HD). The mean anticipation score was 27.6 years for all 102 parent-child pairs. The anticipation means were 13.8, 28.4, 19.8 and 35.8 years for these pair-type groups, respectively. These differences between the age of onset for each affected parent-child pair type were statistically significant. The anticipation level was more pronounced among the NHUNHL pairs than in the HD/HD pairs (difference = 12.6 years, p = 0.0003). These results allow us to conclude with confidence that there is an apparent genetic anticipation in familial HD and NHL in the Swedish population.
本研究的目的是检验霍奇金淋巴瘤(HD)和非霍奇金淋巴瘤(NHL)中是否存在遗传早现现象。我们基于瑞典癌症数据库分析了102对患HD或NHL的亲子对。我们识别出18对同胞对(2对HD和16对NHL)以及102对亲子对(13对HD/HD、56对NHL/NHL、25对HD/NHL和8对NHL/HD)。所有102对亲子对的平均早现得分是27.6岁。这些配对类型组的早现均值分别为13.8岁、28.4岁、19.8岁和35.8岁。每种受累亲子对类型的发病年龄之间的这些差异具有统计学意义。早现水平在NHL/NHL对中比在HD/HD对中更明显(差异 = 12.6岁,p = 0.0003)。这些结果使我们能够有信心地得出结论,在瑞典人群的家族性HD和NHL中存在明显的遗传早现现象。